Human colon cancer cell proliferation mediated by the M3 muscarinic cholinergic receptor

Clinical Cancer Research

Volumn 5, Issue 9, 1999, Pages 2532-2539

  Frucht, Harold ^a   Jensen, Robert T ^b   Dexter, Dwayne ^a   Yang, Wan Lin ^a   Xiao, Yinghua ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; CARBACHOL; METHYLSCOPOLAMINE; MUSCARINIC M3 RECEPTOR; OTENZEPAD; PIRENZEPINE;

ARTICLE; CALCIUM MOBILIZATION; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM; CALCIUM SIGNALING; CELL DIVISION; CHO CELLS; COLONIC NEOPLASMS; CRICETINAE; GROWTH SUBSTANCES; HUMANS; KINETICS; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; RECEPTOR, MUSCARINIC M3; RECEPTORS, MUSCARINIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0032884778     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Cancer Facts and Figures. New York: American Cancer Society, 1998.
2. Winawer, S. J., Fletcher, R. H., Miller, L., Godlee, F., Stolar, M. H., Mulrow, C. D., Woolf, S. H., Glick, S. N., Ganiats, T. G., Bond, J. H., Rosen, L., Zapka, J. G., Olsen, S. J., Giardiello, F. M., Sisk, J. E., Van Antwerp, R., Brown-Davis, C., Marciniak, D. A., and Mayer, R. J. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology, 112: 594-642, 1997.
3. Moertel, C. G. Chemotherapy for colorectal cancer. N. Engl. J. Med., 330: 1136-1142, 1994.
4. Kinzler, K. W., and Vogelstein, B. Lessons from hereditary colorectal cancer. Cell, 87: 159-170, 1996.
5. Boland, C. R. The biology of colorectal cancer: implications for pretreatment and follow-up management. Cancer (Phila.), 71: 4180-4186, 1993.
6. Aaronson, S. A. Growth factors and cancer. Science (Washington DC), 254: 1146-1153, 1991.
7. Weinberg, R. A. Tumor suppressor genes. Science (Washington DC), 254: 1138-1146, 1991.
8. Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., and McGuire, W. L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (Washington DC), 235: 177-182, 1987.
9. Lippman, M. E., Dickson, R. B., Bates, S., Knabbe, C., Huff, K., Swain, S., McManaway, M., Bronzert, D., Kasid., A., and Gelmann, E. P. Autocrine and paracrine growth regulation of human breast cancer. Breast Cancer Res. Treat., 7: 59-70, 1986.
10. Progress in Clinical and Biological Research. In: P. Ekman and A. A. Snochowski (eds.), Prostate Cancer and Hormone Receptors, Vol. 23. New York: Alan R. Liss, Inc, 1979.
11. Moody, T. W., Carney, D. N., Cuttitta, F., Quattrocchi, K., and Minna, J. D. High affinity receptors for bombesin/GRP-like peptides on human small cell lung cancer. Life Sci., 37: 105-113, 1985.
12. Trepel, J. B., Moyer, J. D., Cuttitta, F., Frucht, H., Coy, D. H., Natale, R. B., Mulshine, J. L., Jensen, R. T., and Sausville, E. A. A novel bombesin receptor antagonist inhibits automne signals in a small cell lung carcinoma cell line. Biochem. Biophys. Res. Commun., 156: 1383-1389, 1988.
13. Watson, S. A., Durant, L. G., and Morris, D. L. Growth-promoting action of gastrin on human colonic and gastric tumour cells cultures in vitro. Br. J. Surg., 75: 342-345, 1988.
14. Palmer-Smith, J., and Solomon, T. E. Effects of gastrin, proglumide, and somatostatin on growth of human colon cancer. Gastroenterology, 95: 1541-1548, 1988.
15. Frucht, H., Gazdar, A. F., Park, J-A., Oie, H., and Jensen, R. T. Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells. Cancer Res., 52: 1114-1122, 1992.
16. Wess, J. G-protein-coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G-protein recognition. FASEB J., 11: 346-354, 1997.
17. Liu, J., Blin, N., Conklin, B. R., and Wess, J. Molecular mechanisms involved in muscarinic acetylcholine receptor-mediated G protein activation studied by insertion mutagenesis. J. Biol. Chem., 271: 6172-6178, 1996.
18. Wess, J., Liu, J., Blin, N., Yun, J., Lerche, C., and Kostenis, E. Structural basis of receptor/G protein coupling selectivity studied with muscarinic receptors as model systems. Life Sci., 60: 1007-1014, 1997.
19. Kubo, T., Fakuda, K., Mikami, A., Meda, A., Takahashi, H., Mishina, M., Haga, T., Haga, K., Ichiyama, A., Kangawa, K., Kojima, M., Matsuo, H., Hirose, T., and Numa, S. Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor. Nature (Lond.), 323: 411-416, 1986.
20. Kubo, T., Maeda, A., Sugimoto, K., Akiba, I., Mikami, A., Takahashi, H., Haga, T., Haga, K., Ichiyama, A., Kangawa, K., Matsuo, H., Hirose, T., and Numa, S. Primary structure of porcine cardiac muscarinic acetylcholine receptor deduced from the cDNA sequence. FEBS Lett., 209: 367-372, 1986.
21. 2 muscarinic receptor. Science (Washington DC), 236: 600-605, 1987.
22. Peralta, E. G., Ashkenazi, A., Winslow, J. W., Smith, H., Ramachandran, J., and Capon, D. J. Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors. EMBO J., 6: 3923-3929, 1987.
23. Buckley, N. J., Bonner, T. I., Buckley, C. M., and Brann, M. R. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol. Pharmacol., 35: 469-476, 1989.
24. Barnard, E. A. Separating receptor subtypes from their shadows. Nature (Lond.), 335: 301-302, 1988.
25. Brown, J. H., Sah, V., Moskowitz, S., Ramirez, T., Collins, L., Post, G., and Goldstein, D. Pathways and roadblocks in muscarinic receptor-mediated growth regulation. Life Sci., 60: 1077-1084, 1997.
26. Park, J. G., Herbert, K. O., Sugarbaker, P. H., Henslee, J. G., Chen, T. R., Johnson, B. E., and Gazdar, A. Characteristics of cell lines established from human colorectal carcinoma. Cancer Res., 47: 6710-6718, 1987.
27. Munson, P. J., and Rodbard, D. A. A versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem., 107: 220-239, 1980.
28. 50) of an enzymatic reaction. Biochem. Pharmacol., 22: 3099-3108, 1973.
29. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
30. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem., 260: 3440-3450, 1985.
31. Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., and Boyd, M. R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst., 82: 1107-1112, 1990.
32. Wall, S. J., Yasuda, R. P., Li, M., and Wolf, B. B. Development of an antiserum against m3 muscarinic receptors: distribution of m3 receptors in rat tissues and clonal cell lines. Mol. Pharmacol., 40: 783-789, 1991.
33. Gilman, A. G. Guanine nucleotide-binding regulatory proteins and dual control of adenylate cyclase. J. Clin. Invest., 73: 1-4, 1984.
34. + currents of muscarinic acetylcholine receptor subtypes in NG108-15 cells. Nature (Lond.), 335: 55-358, 1988.
35. Peralta, E. G., Ashkenazi, A., Winslow, J. W., Ramachandran, J., and Capon, D. J. Differential regulation of PI hydrolysis and adenylyl cyclase by muscarine receptor subtypes. Nature (Lond.), 334: 434-437, 1988.
36. Kohn, E. C., Sandeen, M. A., and Liotta, L. A. In vivo efficacy of a novel inhibitor of selected signal transduction pathways including calcium, arachidonate, and inositol phosphates. Cancer Res., 52: 3208-3212, 1992.
37. Singer-Lahat, D., Liu, J., Wess, J., and Felder, C. C. The third intracellular domain of the m3 muscarinic receptor determines coupling to calcium influx in transfected Chinese hamster ovary cells. FEBS Lett., 386: 51-54, 1996.
38. Mitchelson, F. Muscarinic receptor differentiation. Pharmacol. Ther., 37: 357-423, 1996.
39. Alexander, S. P. H., and Peters, J. A. Receptor and ion channel nomenclature supplement. Trends Pharmacol. Sci., 19 (Suppl.): 1-98, 1998.
40. Sutliff, V. E., Rattan, S., Gardner, J. D., and Jensen, R. T. Characterization of cholinergic receptors mediating pepsinogen secretion from chief cells. Am. J. Physiol., 257: G226-G234, 1989.